ベータ
治験レーダーAI
治験 NCT06554340(対象:多発性硬化症、高血圧)は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。
フィルター基準に一致する試験が1件見つかりました
タイル表示

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

募集中
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます!「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT06554340介入研究 臨床試験 で、多発性硬化症、高血圧 に関するものです。現在は 募集中 で、2025年4月15日 から開始しています。80 名の参加者 の募集が計画されています。この治験は University of Massachusetts, Boston によって主催され、2027年8月1日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2025年8月22日 です。
概要

The goal of this study is to determine if 12 weeks of cycling exercise training at home will improve three parameters: 1) blood pressure, 2) cognition, and 3) walking ability among persons with multiple sclerosis who have high blood pressure, when compared to a group that engages in a 12-week home-based stretching program.

The main questions this study aims to answer are:

  1. Can home-based cycling exercise training improve blood pressure by increasing blood vessel dilation in people with multiple sclerosis?
  2. Can cycling exercise training improve cognition and walking mobility in people with multiple sclerosis by improving blood pressure?

The investigators will compare home-based cycling training to stretching to see if cycling training improves cognition, walking mobility, blood pressure, and fitness in people with multiple sclerosis.

Participation in this study will take 13-14 weeks, with participants being randomized (like flipping a coin, a 50-50 chance of being in either group) to the home-based cycling training or the stretching group.

All participants will be asked to

  • Visit the laboratory two times, one before the beginning of the intervention (home-base training and stretching group) and one at the end of the intervention.
  • During visits, participants will complete tests related to cognition, walking mobility, blood pressure and fitness.
詳細説明

Functionally, the disease pathophysiology of multiple sclerosis (MS) brings about a number of consequences, including cognitive dysfunction and mobility disability, which are two of the most prevalent outcomes of MS. Cognitive impairments typically occur in domains of mental processing speed and working memory and is present in 40-70% of patients with MS based on neuropsychological testing. Cognitive impairment compromises quality of life, activities of daily living, employment, and independent living in persons with MS, and co-occurs with decrements in physical abilities. Mobility disability presents as slowed walking speed and reduced walking endurance and presents in nearly 75% of persons with MS population. Cognitive dysfunction and mobility disability might be worsened through the presence of co-morbid conditions that are manageable through life-style behaviors in MS.

Hypertension is the most prevalent cardiovascular comorbidity in MS and is 25% more common in MS than the general population. Yet, there is truly a dearth of research investigating the unique and understudied population of hypertensives with MS. Importantly, hypertension produces vascular changes causing increased blood pressure (BP) pulsatility. The increased pulsatility has been associated with detrimental changes in the brain in the general population and persons with MS. The investigators have shown that BP pulsatility is inversely associated with mobility in people with MS, and that elevated BP is associated with worse cognition in MS. This suggests that mitigating hypertension and decreasing BP pulsatility through lifestyle behaviors may represent important mechanistic pathways for exerting functional adaptations in cognition and mobility for people with MS.

Physical activity and exercise training are effective approaches for improving vascular hemodynamics and BP in the general population of person with hypertension. The investigators have shown that endothelial function and arterial stiffness, which are two important mechanisms related to hypertension, are associated with physical activity in people with MS. The investigators have further shown that exercise training improves endothelial function, mobility, and cognitive function in people with MS. This suggests that exercise training may improve cognition and mobility through vascular outcomes in persons with MS who have hypertension.

The existing studies that improve cardiovascular fitness, cognitive function, and mobility in persons with MS have been center-based, directly supervised, and prescreened participants for the absence of risk factors for cardiovascular disease (CVD). This severely limits the scalability and reach of exercise interventions for managing the functional consequences of MS, and no exercise studies, to date, have targeted persons with MS who are hypertensive, thus, it is unknown if the results will transfer or work better in this group who are higher risk of CVD-related outcomes. Based on our previous randomized controlled trial (RCT) funded by the National Multiple Sclerosis Society (Grant RG4702A), The investigators are the first to successfully demonstrate that a 12-week home-based aerobic exercise intervention, coupled with internet-based monitoring and behavioral coaching, is safe and feasible among persons with MS and yielded improvements in aerobic fitness, vascular function, and mobility. However, our RCT was conducted in volunteers with MS who were prescreened for CVD risk factors (i.e., excluded persons with CVD-related comorbidities), but serves as a precursor for conducting a similar RCT in persons with cardiovascular comorbidities, such as hypertension. The proposed study aims to address this important gap and underrepresented population.

Our long-term goal involves establishing the scientific basis of home-based exercise training as a therapeutic approach for optimizing functional recovery and quality of life in persons with MS. The objective of this application will follow a RCT design and will evaluate if home-based exercise training can elicit improvements in mechanisms of hemodynamic control related to hypertension and yield clinical benefits for cognition and mobility among persons with MS who have hypertension. This would be the first of its kind RCT ever conducted in persons with MS.

Our central hypothesis is that aerobic exercise training will positively impact cognition and mobility disability (two primary outcomes) and that it will also improve cardiovascular-specific mechanisms of hypertension (secondary outcomes). Exercise training improves hypertension, and hypertension is negatively associated with cognition and mobility in older adults and persons with Alzheimer's disease. The investigators believe that a well-designed aerobic exercise training stimulus is likely to improve hypertension-related mechanisms, which will positively impact cognition and mobility disability in persons with MS, thus improving functional recovery. This central hypothesis will be addressed by pursuing two main specific aims and one exploratory specific aim via a 12-week home-based aerobic exercise training program among persons with MS who have hypertension compared with an attention-control program:

  1. Specific Aim 1 is to determine if the intervention improves functional outcomes related to cognition, specifically information processing speed, and mobility in hypertensives with MS. Our working hypothesis is that 12 weeks of aerobic exercise training will improve information processing speed (symbol digits modality test (SDMT) and California Verbal Learning Test-II (CVLT-II)) and attenuate mobility disability (e.g., timed 25-foot walk), which are important markers of functional outcomes.
  2. Specific Aim 2 will determine if vascular function and BP improve with exercise training compared with control. Our working hypothesis is that 12 weeks of aerobic exercise training will reduce BP and pulsatility, while also improving vascular-specific mechanisms related to hypertension (e.g., endothelial function and arterial stiffness).
  3. Specific Aim 3 is exploratory and will determine if the change in BP and vascular function can account for the change in cognition and/or mobility following exercise training. Our exploratory hypothesis is that changes in vascular function and BP will be associated with changes in cognition and walking mobility.
公式タイトル

Targeting Vascular Mechanisms of Functional Outcomes Via Home-based Exercise Training Among Persons With Multiple Sclerosis Who Have Hypertension

疾患/病気
多発性硬化症高血圧
その他の研究識別子
  • 3616
NCT番号
開始日
2025-04-15
最終更新日
2025-08-22
終了予定日
2027-08
目標参加者数
80
試験の種類
介入研究
治験の相・段階
該当なし
状況
募集中
キーワード
exercise
blood pressure
mobility
cognition
主目的
治療
割付方法
無作為化
介入モデル
並行割当
盲検化
なし(非盲検)
群(アーム)/介入
参加グループ/群介入/治療法
実験的Home-based aerobic training
A 3-month home-based exercise training intervention comprising cycle ergometry as an aerobic mode of training coupled with behavioral coaching. The regimen will be delivered 3-4 days per week.
Home-based Aerobic Training
The aerobic training will focus on large, dynamic movements of the lower extremities using leg cycling ergometry on an upright cycle ergometer installed in the participant's homes and will progress in duration (10-40 minutes) and intensity (50-70% VO2 peak) over the 3-month intervention period. All participants will start exercise at 50% of VO2peak for 10-min as determined by the exercise test, for the first week, to individualize the exercise prescription. Progression will initially target duration with weekly progressions of 5 min to 30 min of exercise, followed by progression of intensity by 5% per week until 70% is attained, based on patient tolerance of the increased work.
非介入Attention control
The alternative treatment condition comprises a stretching program with minimal exercise and attention control. This program will be delivered using the same frequency and duration as the intervention. The first session will be conducted under the supervision of visiting study personnel as described above. The stretching exercises will follow the manual provided by the National Multiple Sclerosis Society and the investigators will progressively include more exercises and sets over the 3 months, this too has been standardized and manualized for reproducibility. The investigators will provide the same materials and Internet coaching for the attention control group as for the intervention group but focused on stretching and not on increasing aerobic exercise. The investigators will ask that participants not undertake additional exercise during the study duration and this will be documented through an exercise history, the Godin Leisure-Time Exercise Questionnaire.
該当なし
主要評価項目
評価指標指標の説明時間枠
Information processing speed
The Brief International Cognitive Assessment (BICAMS) battery tests, including the Symbol Digit Modalities Test (SDMT) and California Verbal Learning Test-II (CVLT-II)
Baseline, pre-intervention/BICAMS; Within 5 days after completion of the training intervention/BICAMS
Timed 25-Foot Walk
Measurement of mobility disability
Baseline, pre-intervention/25-Foot Walk; Within 5 days after completion of training intervention/ 25-Foot Walk
副次評価項目
評価指標指標の説明時間枠
Blood pressure
24h Blood pressure and central systolic blood pressure
Baseline, pre-intervention/oscillometry, applanation tonometry; Within 5 days after completion of training intervention/oscillometry, applanation tonometry
Flow-mediated dilation
Non-invasive measurement of endothelium-dependent vasodilation and macrovascular function
Baseline, pre-intervention/ultrasonography; Within 5 days after completion of training intervention/ultrasonography
Forearm blood flow
Non-invasive measurement of microvascular function
Baseline, pre-intervention/ strain-gauge plethysmography; Within 5 days after completion of training intervention/strain-gauge plethysmography
Cardiorespiratory fitness
Maximal oxygen uptake
Baseline, pre-intervention/indirect calorimetry; Within 5 days after completion of training intervention/indirect calorimetry
適格基準

対象年齢
成人, 高齢者
試験の最低年齢
18 Years
対象性別
全て
  • Persons with confirmed multiple sclerosis diagnosis with Expanded Disability Status Scale scores of 4-6.5, characteristic of 2nd stage of multiple sclerosis;
  • Hypertension defined as elevated, or Stage 1 or 2, as per the 2017 American Heart Association guidelines (brachial systolic blood pressure > 120 mmHg or brachial diastolic blood pressure > 80 mmHg)
  • Persons who are physically inactive (less than 60 min/wk of physical activity);
  • Persons with body mass index < 40 kg/m2;
  • Persons who are not confined to a wheel chair;
  • Multiple sclerosis relapse in the past 30 days;
  • People with stable pharmacotherapy.

  • People with additional cardiovascular comorbidities;
  • People with type 1 diabetes mellitus;
  • Physician disapproval to participating in the study;
  • Space constraints to fit a cycle ergometer at the home of prospective participants.
University of Massachusetts, Boston logoUniversity of Massachusetts, Boston
責任者
Tracy Baynard, 研究責任者, Professor and Assoc Vice Provost, Grad Edu, University of Massachusetts, Boston
試験中央連絡先
連絡先: Tracy Baynard, PhD, 2178404493, [email protected]
連絡先: Joao L Maroco, MS, 7738933897, [email protected]
1 1カ国の場所

Massachusetts

UMass Boston, Boston, Massachusetts, 02125, United States
募集中